A p18INK4C inhibitor
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

P18IN003

Item No. 46505

Technical Information
Formal Name
1,3-dihydro-4,5-bis(4-methoxyphenyl)-2H-imidazol-2-one
CAS Number
71727-40-7
Molecular Formula
C17H16N2O3
Formula Weight
Purity
≥98%
A solid
SMILES
O=C1NC(C2=CC=C(OC)C=C2)=C(C3=CC=C(C=C3)OC)N1
InChi Code
InChI=1S/C17H16N2O3/c1-21-13-7-3-11(4-8-13)15-16(19-17(20)18-15)12-5-9-14(22-2)10-6-12/h3-10H,1-2H3,(H2,18,19,20)
InChi Key
JOTSGKDUQMLZLE-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    P18IN003 is an inhibitor of p18INK4C.1 It increases the number of cobblestone islands in long-term cultures of isolated mouse bone marrow nucleated cells (BMNCs), indicating an increase in the frequency of primitive hematopoietic cells, in a p18INK4C-dependent manner. P18IN003 (20 nM) sensitizes p16highpRbhigh patient-derived breast cancer cells to the cyclin-dependent kinase 4 (Cdk4) and Cdk6 inhibitor ribociclib (LEE011; Item No. 17666).2 It has been used to promote the expansion of hematopoietic cells in vitro prior to competitive bone marrow transplant in mice.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Gao, Y., Yang, P., Shen, H., et al. Small-molecule inhibitors targeting INK4 protein p18INK4C enhance ex vivo expansion of haematopoietic stem cells. Nat. Commun. 6, 6328 (2015).

    2. Palafox, M., Monserrat, L., Bellet, M., et al. Author correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer. Nat. Commun. 13(1), 6928 (2022).